ARA-290 · 10mg Research Vial ghk-cu In vitro research interest focuses

In vitro research interest focuses on pulsatile GHRH receptor stimulation studies

NAD+ precursor pathway research

and anti-inflammatory mechanisms

This 10mg vial provides double the concentration of our standard vial for advanced in vitro applications

neuroprotective signalling studies

ARA-290 · 10mg Research Vial ghk-cu In vitro research interest focusesFOR RESEARCH USE ONLY NOT FOR HUMAN CONSUMPTION ARA 290 is an 11 amino acid synthetic peptide derived from the helix B region of erythropoietin (EPO), engineered to selectively bind the innate repair receptor (IRR) without interaction with the classical EPO receptor responsible for erythropoiesis. In vitro research interest focuses on IRR mediated cytoprotective signalling, anti inflammatory cytokine modulation, and small fibre nerve research models.